Billionaire Carl Icahn had called the deal a "$60 billion folly," but is now walking back his opposition in light of recommendations from Institutional Shareholder Services and Glass Lewis. The latter called the insurer’s offer for the pharmacy benefits manager “both strategically and financially compelling, structured in a reasonable manner from a valuation standpoint for Cigna shareholders.”
from Kaiser Health News https://ift.tt/2Mm5wgx
August 14, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: Ryan’s Big Failure: Not Cutting Health Care Costs; GOP Mounts End Run Around Obamacare Even While ACA’s Popularity GrowsEditorial pages focus on these and other health topics. from Kaiser Health News https://ift.tt/2EG0YtI … Read More
Longer Looks: Children’s ER Bills; Life And Death For Black Mothers; John Oliver On Crisis Pregnancy CentersEach week, KHN's Shefali Luthra finds interesting reads from around the Web. from Kaiser Health News https://ift.tt/2qqW2o5 … Read More
CRISPR Has Made Its Way Into Popular Culture. How Accurate Is The Portrayal Of The Gene-Editing Technique?"Rampage" is the latest movie to feature CRISPR as a plot device. Stat takes a look at what it gets right and wrong. In other public health news: exercise, OB-GYNs, heart valves, memory loss, and a criminal investigation of a… Read More
Risk For Zika Through Sexual Transmission May Last For Shorter Time Than Originally ThoughtA new study finds that the risk appears to dissipate after one month. But experts say they're not willing to change guidelines just quite yet. from Kaiser Health News https://ift.tt/2EFIuta … Read More
State Highlights: Texas’ Startlingly High Maternity Death Rate Was Actually A Miscalculation; Colorado Reports Surgical InfectionsMedia outlets report on news from Texas, Colorado, Georgia, Arizona, Ohio, Maryland, Tennessee, Missouri, Illinois and New York. from Kaiser Health News https://ift.tt/2IKP04w … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment